Mar 29, 2009

Diethylstilbestrol (DES) linked to a rare vaginal cancer.

Diethylstilbestrol (DES) is a drug once prescribed during pregnancy to prevent miscarriages or premature deliveries. In the U.S. an estimated 5 to 10 million persons were exposed to DES from 1938 to 1971, including pregnant women prescribed DES and their children. In 1971, the Food and Drug Administration (FDA) advised physicians to stop prescribing DES because it was linked to a rare vaginal cancer.

No comments:

Post a Comment

No Anonymous comments or SPAM allowed. I welcome all on topic comments and civil discourse.